Medicines showing this symbol are subject to additional monitoring. This will allow quick identification of new safety information. Please click here for more information.
- Active Ingredients
Product Documentation
-
View RMM (Jubereq (denosumab) Patient Reminder Card)
Last updated on this site: 19 Dec 2025
New Product Launch.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintJubereq 120 mg solution for injection
Medicines showing this symbol are subject to additional monitoring. This will allow quick identification of new safety information. Please click here for more information.
- PL Number:
- PL 20075/1576
- MA Holder:
- Accord Healthcare Limited
- Product Classification:
-
POM
- Product Status:
- Active
Product Documentation
-
View Patient Information Leaflet (PIL - Jubereq 120 mg solution for injection)
Last updated on this site: 18 Dec 2025
New Product Launch.
View Summary of Product Characteristics (SmPC - Jubereq 120 mg solution for injection)Last updated on this site: 18 Dec 2025
New Product Launch
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaint
For any further assistance, please get in touch.